As of 2026-10-07, the Fair Value of Inozyme Pharma Inc (INZY) is -8.26 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.00 USD, the upside of Inozyme Pharma Inc is -306.62%.
With the market price of 4.00 USD and our fair value calculation, Inozyme Pharma Inc (INZY) is not a good investment. Investing in INZY stocks now will result in a potential loss of 306.62%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -56.42 | -56.62 | -67.06 | -71.17 | -102.02 | -70.66 |
| YoY growth | -186.11% | -0.35% | -18.44% | -6.13% | -43.35% | -50.88% |
| Market Cap (mil) | 258.24 |
| P/E | |
| Forward P/E |
| EPS | -1.65 |
| Avg earnings growth rate | -50.88% |
| TTM earnings | -106.72 |